Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,755 | 456 | 96.0% |
| Education | $341.93 | 4 | 3.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.10 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,140 | 93 | $0 (2024) |
| Janssen Biotech, Inc. | $979.91 | 70 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $678.01 | 28 | $0 (2024) |
| Amgen Inc. | $612.83 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $579.39 | 31 | $0 (2024) |
| LEO Pharma Inc. | $531.50 | 34 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $413.89 | 24 | $0 (2023) |
| Celgene Corporation | $388.70 | 16 | $0 (2019) |
| GENZYME CORPORATION | $333.83 | 17 | $0 (2023) |
| Lilly USA, LLC | $286.00 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,460 | 65 | E.R. Squibb & Sons, L.L.C. ($359.96) |
| 2023 | $1,163 | 58 | Amgen Inc. ($231.48) |
| 2022 | $1,431 | 57 | ABBVIE INC. ($594.12) |
| 2021 | $1,086 | 63 | AbbVie Inc. ($331.58) |
| 2020 | $263.81 | 13 | Sun Pharmaceutical Industries Inc. ($82.18) |
| 2019 | $1,101 | 44 | AbbVie, Inc. ($381.87) |
| 2018 | $1,161 | 79 | Janssen Biotech, Inc. ($264.38) |
| 2017 | $1,456 | 82 | Janssen Biotech, Inc. ($245.92) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Immunology | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $94.89 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.22 | General |
| Category: Immunology | ||||||
| 10/30/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.34 | General |
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $130.42 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.04 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,978 | 3,343 | $299,200 | $113,145 |
| 2022 | 12 | 1,884 | 3,460 | $294,482 | $106,806 |
| 2021 | 14 | 1,985 | 3,487 | $307,249 | $116,349 |
| 2020 | 12 | 1,961 | 3,153 | $247,937 | $89,440 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 499 | 664 | $79,680 | $37,457 | 47.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 275 | 329 | $47,047 | $21,470 | 45.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 342 | 411 | $48,498 | $13,695 | 28.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 333 | 384 | $24,960 | $13,138 | 52.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 260 | 1,263 | $37,890 | $5,594 | 14.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 81 | 81 | $12,150 | $5,520 | 45.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 28 | 32 | $16,640 | $3,667 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 35 | $4,900 | $2,872 | 58.6% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 18 | 20 | $7,100 | $2,450 | 34.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 18 | $5,490 | $1,822 | 33.2% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 39 | 43 | $5,203 | $1,781 | 34.2% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 16 | 19 | $4,465 | $1,673 | 37.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 33 | 33 | $3,630 | $1,290 | 35.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 11 | $1,547 | $718.13 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 430 | 550 | $66,000 | $31,572 | 47.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 267 | 306 | $43,758 | $19,761 | 45.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 356 | 443 | $52,274 | $15,207 | 29.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 350 | 402 | $26,130 | $14,910 | 57.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 254 | 1,518 | $45,540 | $6,791 | 14.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 42 | 52 | $27,040 | $5,400 | 20.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $10,800 | $5,101 | 47.2% |
| 11641 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 18 | 18 | $8,370 | $2,645 | 31.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 40 | 40 | $4,400 | $1,825 | 41.5% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2022 | 13 | 16 | $4,720 | $1,398 | 29.6% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2022 | 30 | 30 | $3,630 | $1,374 | 37.8% |
About Dr. Stanley Capper, MD
Dr. Stanley Capper, MD is a Dermatology healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710915210.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanley Capper, MD has received a total of $9,122 in payments from pharmaceutical and medical device companies, with $1,460 received in 2024. These payments were reported across 461 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($8,755).
As a Medicare-enrolled provider, Capper has provided services to 7,808 Medicare beneficiaries, totaling 13,443 services with total Medicare billing of $425,740. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Wichita, KS
- Active Since 06/30/2006
- Last Updated 09/30/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1710915210
Products in Payments
- SKYRIZI (Biological) $719.66
- Otezla (Drug) $711.59
- Sotyktu (Drug) $678.01
- RINVOQ (Biological) $465.17
- Humira (Biological) $445.46
- TREMFYA (Drug) $349.86
- REMICADE (Biological) $305.66
- ENSTILAR (Drug) $289.90
- STELARA (Biological) $283.55
- HUMIRA (Biological) $278.68
- TALTZ (Drug) $261.50
- ADBRY (Biological) $241.60
- DUPIXENT (Biological) $231.44
- Skyrizi (Biological) $180.93
- DUPIXENT (Drug) $174.42
- DUPIXENT DUPILUMAB INJECTION (Biological) $152.78
- Tremfya (Drug) $147.75
- COSENTYX (Biological) $130.72
- Absorica LD (Drug) $128.65
- COSENTYX (Drug) $113.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Wichita
Brandon Litzner, Md, MD
Dermatology — Payments: $15,663
Dr. Chelsea Lee, Do, DO
Dermatology — Payments: $6,543
Mr. Landon Johnson, M.d, M.D
Dermatology — Payments: $6,127
Krista Shackelford, M.d, M.D
Dermatology — Payments: $2,818
Faith Vautravers, Pa-C, PA-C
Dermatology — Payments: $2,225
Dr. Christopher Moeller, Md, MD
Dermatology — Payments: $1,768